Literature DB >> 21126830

Antecedents and correlates of methadone treatment entry: a comparison of out-of-treatment and in-treatment cohorts.

Robert P Schwartz1, Sharon M Kelly, Kevin E O'Grady, Shannon Gwin Mitchell, Barry S Brown.   

Abstract

BACKGROUND: The majority of opioid-dependent individuals in the US in need of drug treatment are not receiving it. It would be useful to understand the characteristics of individuals entering and failing to enter methadone treatment.
METHODS: Participants were opioid-dependent adults in Baltimore Maryland recruited from new admissions to one of six methadone treatment programs (n=351) and from the streets from among non-treatment seekers (n=164). At study enrollment, participants were administered the Addiction Severity Index, AIDS Risk Assessment, Community Assessment Inventory, Attitudes toward Methadone Scale, Motivation for Treatment Scale and a urine drug test. A series of logistic regression analyses were conducted to determine the best model to predict treatment entry.
RESULTS: The final logistic regression analysis showed that predictors of treatment entry included: being African-American, being on parole or probation, having lower rates of self-reported cocaine use and criminal activity, higher employment functioning, and greater perceptions of support from family and community for behavioral change. In addition, in-treatment participants were more likely to have a more extensive prior history of drug abuse treatment, greater desire to seek help in coping with their drug problem, and more positive view of methadone.
CONCLUSIONS: The distinctions between those entering and those not pursuing MTP entry have significance for the structure of outreach programs and reaffirm the need to supplement the current practices of voluntary and coerced treatment entry with one of encouraged treatment entry through outreach.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21126830      PMCID: PMC3059350          DOI: 10.1016/j.drugalcdep.2010.10.016

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  42 in total

1.  Efficacy, individual effectiveness, and population effectiveness in substance abuse treatment.

Authors:  G E Woody; A Muñoz
Journal:  Curr Psychiatry Rep       Date:  2000-12       Impact factor: 5.285

2.  Modeling year 1 outcomes with treatment process and post-treatment social influences.

Authors:  D D Simpson; G W Joe; J M Greener; G A Rowan-Szal
Journal:  Subst Use Misuse       Date:  2000 Oct-Dec       Impact factor: 2.164

3.  Dynamics of behavioral risk factors for HIV/AIDS: a 6-year prospective study of injection drug users.

Authors:  D D Celentano; A Muñoz; S Cohn; D Vlahov
Journal:  Drug Alcohol Depend       Date:  2001-02-01       Impact factor: 4.492

4.  Evaluation of a minimal services treatment track for noncompliant patients in opioid substitution treatment.

Authors:  Donald A Calsyn; Frank J DeMarco; Andrew J Saxon; Kevin L Sloan; Karen E Gibbon
Journal:  Am J Public Health       Date:  2003-07       Impact factor: 9.308

5.  Improving entry to methadone maintenance among out-of-treatment injection drug users.

Authors:  Robert E Booth; Karen F Corsi; Susan K Mikulich
Journal:  J Subst Abuse Treat       Date:  2003-06

6.  Opioid agonist maintenance for probationers: patient-level predictors of treatment retention, drug use, and crime.

Authors:  Jan Gryczynski; Timothy W Kinlock; Sharon M Kelly; Kevin E O'Grady; Michael S Gordon; Robert P Schwartz
Journal:  Subst Abus       Date:  2012       Impact factor: 3.716

7.  Factors predicting entry of injecting drug users into substance abuse treatment.

Authors:  W A Zule; D P Desmond
Journal:  Am J Drug Alcohol Abuse       Date:  2000-05       Impact factor: 3.829

8.  The Community Assessment Inventory--client views of supports to drug abuse treatment.

Authors:  Barry S Brown; Kevin E O'Grady; Robert J Battjes; Elizabeth C Katz
Journal:  J Subst Abuse Treat       Date:  2004-10

9.  Changes in attitude toward methadone.

Authors:  B S Brown; D R Jansen; G J Benn
Journal:  Arch Gen Psychiatry       Date:  1975-02

10.  Drug user treatment referrals and entry among participants of a needle exchange program.

Authors:  Elise D Riley; Mahboobeh Safaeian; Steffanie A Strathdee; Robert K Brooner; Peter Beilenson; David Vlahov
Journal:  Subst Use Misuse       Date:  2002       Impact factor: 2.164

View more
  16 in total

1.  The role of perceived belongingness to a drug subculture among opioid-dependent patients.

Authors:  Samantha J Moshier; R Kathryn McHugh; Amanda W Calkins; Bridget A Hearon; Anthony J Rosellini; Meara L Weitzman; Michael W Otto
Journal:  Psychol Addict Behav       Date:  2012-06-25

2.  Forced withdrawal from methadone maintenance therapy in criminal justice settings: a critical treatment barrier in the United States.

Authors:  Jeannia J Fu; Nickolas D Zaller; Michael A Yokell; Alexander R Bazazi; Josiah D Rich
Journal:  J Subst Abuse Treat       Date:  2013-02-22

3.  Interim methadone and patient navigation in jail: Rationale and design of a randomized clinical trial.

Authors:  Robert P Schwartz; Sharon M Kelly; Shannon G Mitchell; Laura Dunlap; Gary A Zarkin; Anjalee Sharma; Kevin E O'Grady; Jerome H Jaffe
Journal:  Contemp Clin Trials       Date:  2016-06-07       Impact factor: 2.226

4.  Ethnic differences in psychosocial factors in methadone maintenance: Hmong versus non-Hmong.

Authors:  Gavin Bart
Journal:  J Ethn Subst Abuse       Date:  2017-11-09       Impact factor: 1.507

5.  Attitudes Toward Addiction, Methadone Treatment, and Recovery Among HIV-Infected Ukrainian Prisoners Who Inject Drugs: Incarceration Effects and Exploration of Mediators.

Authors:  Maxim Polonsky; Julia Rozanova; Lyuba Azbel; Chethan Bachireddy; Jacob Izenberg; Tetiana Kiriazova; Sergii Dvoryak; Frederick L Altice
Journal:  AIDS Behav       Date:  2016-12

6.  Heroin Use, HIV-Risk, and Criminal Behavior in Baltimore: Findings from Clinical Research.

Authors:  Robert P Schwartz; Sharon M Kelly; Jan Gryczynski; Shannon Gwin Mitchell; Kevin E O'Grady; Jerome H Jaffe
Journal:  J Addict Dis       Date:  2015

7.  Redefining retention: recovery from the patient's perspective.

Authors:  Shannon Gwin Mitchell; Rika Morioka; Heather Schacht Reisinger; James A Peterson; Sharon M Kelly; Michael H Agar; Barry S Brown; Kevin E O'Grady; Robert P Schwartz
Journal:  J Psychoactive Drugs       Date:  2011 Apr-Jun

8.  Improvements in outcomes in methadone patients on probation/parole regardless of counseling early in treatment.

Authors:  Sharon M Kelly; Kevin E Oʼgrady; Jerome H Jaffe; Devang Gandhi; Robert P Schwartz
Journal:  J Addict Med       Date:  2013 Mar-Apr       Impact factor: 3.702

9.  Supporting individuals using medications for opioid use disorder in recovery residences: challenges and opportunities for addressing the opioid epidemic.

Authors:  Jennifer Miles; Jason Howell; Dave Sheridan; George Braucht; Amy Mericle
Journal:  Am J Drug Alcohol Abuse       Date:  2020-02-24       Impact factor: 3.829

10.  Patient perspectives on choosing buprenorphine over methadone in an urban, equal-access system.

Authors:  Jan Gryczynski; Jerome H Jaffe; Robert P Schwartz; Kristi A Dušek; Nishan Gugsa; Cristin L Monroe; Kevin E O'Grady; Yngvild K Olsen; Shannon Gwin Mitchell
Journal:  Am J Addict       Date:  2013 May-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.